SNW1 is a prognostic biomarker in prostate cancer

• Main Authors: Doris Höflmayer (Author), Carla Willich (Author), Claudia Hube-Magg (Author), Ronald Simon (Author), Dagmar Lang (Author), Emily Neubauer (Author), Frank Jacobsen (Author), Andrea Hinsch (Author), Andreas M. Luebke (Author), Marie Christina Tsourlakis (Author), Hartwig Huland (Author), Markus Graefen (Author), Alexander Haese (Author), Hans Heinzer (Author), Sarah Minner (Author), Franziska Büscheck (Author), Guido Sauter (Author), Thorsten Schlomm (Author), Stefan Steurer (Author), Till S. Clauditz (Author), Eike Burandt (Author), Waldemar Wilczak (Author), Christian Bernreuther (Author)
• Format: Book
• Published: BMC, 2019-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background SNW1 is a nuclear receptor co-activator involved in splicing and transcription control, including androgen receptor signaling. Overexpression of SNW1 has been linked to adverse prognosis in different cancer types, but studies on the role of SNW1 in prostate cancer are lacking. Me...